Familial aggregation in giant cell arteritis and polymyalgia rheumatica: A comprehensive literature review including 4 new families

Clinical and Experimental Rheumatology

Volumn 27, Issue 1 SUPPL. 52, 2009, Pages

  Liozon, Eric ^a   Ouattara, Baly ^a   Rhaiem, Kaïef ^a   Ly, Kim ^a   Bezanahary, Holy ^a   Loustaud, Véronique ^a   Letellier, Philippe ^b   Drouet, Mireille ^a   Vidal, Elisabeth ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Environmental factors; Familial aggregation; Genetic factors; Giant cell arteritis; Polymyalgia rheumatica

Indexed keywords

HLA ANTIGEN; PREDNISOLONE;

BLOOD VESSEL BIOPSY; FAMILY; GIANT CELL ARTERITIS; HLA TYPING; HUMAN; IMMUNOGENETICS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATIC POLYMYALGIA; SIBLING;

AGED; ENVIRONMENTAL EXPOSURE; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GIANT CELL ARTERITIS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; RECURRENCE;

EID: 70450240812     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. SALVARANI C, CANTlNI F, BOIARDI L, HUNDER GG: Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002; 347: 261-71.
2. WEYAND CM, GORONZY JJ: Giant cell arteritis as an antigen driven disease. Rheum Dis Clin North Am 1995; 21: 1027-1039
3. MAKSIMOWICZ-MCKINNON K, HOFFMAN GS: Large vessel vasculitis. Clin Exp Rheumatol 2007; 25 (Suppl. 44): S58-9.
4. DASGUPTA B, HASSAN N; BRITISH SOCIETY FOR RHEUMATOLOGY GUIDELINES GROUP: Giant cell arteritis: recent advances and guidelines for management. Clin Exp Rheumatol 2007; 25 (Suppl. 44): S62-5.
5. PITIPONE N, BOIARDI L, BAJOCCHI G, SALVARANI C: Long term outcome of giant cell arteritis. Clin Exp Rheumatol 2006; 24 (Suppl. 41): S65-70.
6. DUHAUT P, BOSSHARD S, CALVET A et al.: Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. J Rheumatol 1999; 26: 361-369
7. SALVARANI C, GABRIEL SE, O'FALLON WM, HUNDER GG: The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995; 123: 192-194
8. BAS-LANDO M, BREUER GS, BERKUN Y, MATES M, SONNENBLICK M, NESHER G: The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations. Clin Exp Rheumatol 2001; 25 (Suppl. 44): S15-7.
9. GONZALEZ-GAY MA, MIRANDA-FILLOY JA, LOPEZ-DIAZ MJ et al.: Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. Medicine 2007; 86: 61-68 (Pubitemid 46668055)
10. PETURSDOTTIR V, JOHANSSON H, NORDBORG E, NORDBORG C: The epidemiology of giant cell arteritis: special references to cyclic fluctuations. Rheumatology 1999; 38: 1208-1212
11. ELLING P, OLSSON AT, ELLING H: Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark: association with epidemics of mycoplasma pneumoniae infection. J Rheumatol 1996; 23: 112-119
12. RUSSO MG, WAXMAN J, ABDOH AA, SEREBRO LH: Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism? Arthritis Rheum 1995; 38: 374-380
13. NORDBORG C, NORDBORG E, PETURSDOTTIR V et al.: Search for varicella zoster virus in giant cell arteritis. Ann Neurol 1998; 44: 413-414
14. GABRIEL SE, ESPY M, ERDMAN DD, BJORNSSON J, SMITH TF, HUNDER GG: The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis Rheum 1999; 42: 1255-1258
15. WAGNER AD, GERARD HC, FRESEMANN T et al.: Detection of chlamydia pneumoniae in giant cell vasculitis and correlation with topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum 2000; 43: 1543-1551
16. HAUGEBERG G, BIE R, NORDBO SA: Chlamydia pneumoniae not detected in temporal biopsies from patients with temporal arteritis. Scand J Rheumatol 2000; 29: 127-8.
17. SALVARANI C, FARNETTI E, CASALI B et al.: Detection of parvovirus B19 DNA by polymerase chain reaction in giant cell arteritis: a case-control study. Arthritis Rheum 2002; 46: 3099-3101
18. HELWEG-LARSEN J, TARP B, OBEL N, BASLUND B: No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal arteriy biopsies in patients with giant cell arteritis. Rheumatology 2002; 41: 445-449
19. REGAN MJ, WOOD BJ, HSIEH Y-H et al.: Temporal arteritis and chlamydia pneumoniae. Failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls. Arthritis Rheum 2002; 46: 1056-1060
20. RODRIGUEZ-PLA A, BOSCH-GIL JA, ECHEVARRIA-MAYO JE et al.: No detection of parvovirus or herpesvirus DNA in giant cell arteritis. J Clin Virol 2004; 31: 11-15
21. ALVAREZ-LAFUENTE R, FERNANDEZ-GUTTIEREZ B, JOVER JA et al.: Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction. Ann Rheum Dis 2005; 64: 780-782
22. POWERS JF, BEDRI S, HUSSEIN S, SALOMON RN, TISCHLER AS: High prevalence of herpes simplex virus DNA in temporal arteritis biopsy specimens. Am J Clin Pathol 2005; 123: 261-264
23. LLORCA J, BRINGAS-BOLLADA M, AMOR-DORADO JC, GARCIA-PORRUA C, GONZALEZ-GAY MA: Lack of association between altitude and incidence of giant cell arteritis in Northwest Spain. Clin Exp Rheumatol 2004; 22: 270.
24. NORDBORG C, NORDBORG E, PETURSDOTTIR V: Giant cell arteritis. Epidemiology, etiology and pathogenesis. APMIS 2000; 108: 713-724
25. BARRIER JH, BIGNON JD, SOULILLOU JP, GROLLEAU J: Increased prevalence of HLA-DR4 in giant cell arteritis. N Engl J Med 1981; 305: 104-105
26. RICHARDSON JE, GLADMAN DD, FAM A, KEYSTONE EC: HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome. Arthritis Rheum 1987; 30: 1293-1297
27. CID MC, ERCILLA G, VILLASECA J et al: Polymyalgia rheumatica: a syndrome associated with HLA-DR4 antigen. Arthritis Rheum 1988; 31: 678-682 (Pubitemid 18146533)
28. WEYAND CM, HUNDER NN, HICOK KC, HUNDER GG, GORONZY JJ: HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994; 37: 514-520
29. GONZALEZ-GAY MA: Genetic epidemiology. Giant cell arteritis and polymyalgia rheumatica. Arthritis Res 2001; 3: 154-157
30. RAUZY O, FORT M, NOURHASHEMI F et al.: Relation between HLA DRB1 alleles and corticosteroid resistance in giant cell arteritis. Ann Rheum Dis 1998; 57: 380-382
31. GONZALEZ-GAY MA, AMOLI MM, GARCIA-PORRUA C, OLLIER WE: Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 2003; 33: 38-48.
32. KEMP A: Monozygotic twins with temporal arteritis and ophthalmic arteritis. Acta Opththalmol 1977; 55: 183-190
33. KVERNEBO K, BRATH HK: Polymyalgia arteritica. A report of five cases within a family. Scand J Rheumatol 1980; 9: 187-189
34. PETIT A, DUPONT B, SANSONETTI P, RAFFOUX C, LAPRESLE C: Maladie de Horton. Etude du groupe HLA. A propos de 3 cas familiaux. Presse Med 1983; 12: 2536.
35. NINET J, GEBUHRER L, BETUEL H, DEBEAUX P, JAMBON-GENET A, PASQUIER J: Maladie de Horton familiale. Relation éventuelle avec l'haplotype HLA, A28, Cw3, B15, DR4. Presse Med 1983; 12: 2697-2698
36. WERNICK R, DAVEY M, BONAFEDE P: Familial giant cell arteritis: report of an HLA-typed sibling pair and review of the literature. Clin Exp Rheumatol 1994; 12: 63-66
37. SCHWIZER B, PIROVINO M: Die riesenzellarteriitis - eine genetisch determinierte erkrankung? Schweiz Med Wochenschr 1994; 124: 1959-1961
38. FIETTA P, MANGANELLI P, ZANETTI A, NERI TM: Familial giant cell arteritis and polymyalgia rheumatica: aggregation in 2 families. J Rheumatol 2002; 29: 1551-1555 (Pubitemid 34755627)
39. RAPTIS L, PAPPAS G, AKRITIDIS N: Horton's three sisters: familial clustering of temporal arteritis. Clin Rheumatol 2007; 26: 1997-1998
40. DABABNEH A, GONZALEZ-GAY MA, GARCIA-PORRUA C, HAJEER A, THOMSON W, OLLIER W: Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol 1998; 25: 2140-2145
41. GONZALEZ-GAY MA: Giant cell arteritis and polymyalgia rheumatica: two different but overlapping conditions. Semin Arthritis Rheum 2004; 33: 289-293 (Pubitemid 38496037)
42. HUNDER GG, BLOCH BA, MICHEL DA et al.: The American College of Rheumatology 1990: criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-1128
43. HUSTON KA, HUNDER GG, LIE JT, KENNEDY RH, EVELBACH LR: Temporal arteritis. A 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978; 88: 162-167
44. WARRINGTON KJ, MATTESON EL: Management guidelines and outcomes measures in giant cell arteritis (GCA). Clin Exp Rheumatol 2007; 6 (Suppl. 47): 137-141
45. LIOZON E, HERRMANN FR, LY K et al.: Risk factors of visual loss in giant cell (temporal) arteritis. A prospective study of 174 patients with emphasis on thrombocytosis. Am J Med 2001; 111: 211-217 (Pubitemid 32786949)
46. BIRD HA, ESSELINCKX W, DIXON AS, MOWAT AG, WOOD PH: An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979; 38: 434-439
47. CHUANG TY, HUNDER GG, ILSTRUP DM, KURLAND LT: Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982; 97: 672-680
48. GONZALEZ-GAY MA, GARCIA-PORRUA C, SALVARANI C, OLIVIERI I, HUNDER GG: The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol 2000; 27: 2179-2184
49. GONZALEZ-GAY MA, GARCIA-PORRUA C, SALVARANI C, OLIVIERI I, HUNDER GG: Polymyalgia manifestations in different conditions mimicking polymalgia rheumatica. Clin Exp Rheumatol 2000; 18: 755-759
50. WADMAN B, WERNER I: Observations on temporal arteritis. Acta Med Scand 1972; 192: 377-383
51. HAMRIN B: Polymyalgia arteritica. Acta Med Scand, Suppl 1972; 533: 1-131.
52. LIANG CG, SIMKIN PA, HUNDER GG, WILSKE KR, HEALEY LA: Familial aggregation of polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1974; 17: 19-24.
53. HOW J, HIRST PJ, BEWSHER PD, BAIN LS: Familial polymyalgia rheumatica. Scott Med J 1981; 26: 59-61.
54. KIRBY J, FIELDING JF: Familial temporal arteritis. Ir J med Sci 1984; 153: 321-322
55. TANENBAUM M, TENZEL J: Familial temporal arteritis. J Clin Neuro-ophthalmol 1985; 5: 244-248
56. MATHEWSON JA, HUNDER GG: Giant cell arteritis in two brothers. J Rheumatol 1986; 13: 190-192 (Pubitemid 16118747)
57. GROS F, MAILLEFERT JF, BEHIN A et al.: Giant cell arteritis with ocular complications discovered simultaneously in two sisters. Clin Rheumatol 1998; 17: 58-61.
58. BARTOLOME MJ, MARTINEZ-TABOADA, LOPEZ-HOYOS M, BLANCO R, RODRIGUEZ-VALVERDE V: Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis. Clin Exp Rheumatol 2001; 19: 259-264
59. NOVAK MA, GREEN WR, MILLER NR: Familial giant cell arteritis. J Clin Neuro-ophthalmol 1986; 6: 126-127
60. ZAUBER P, ZHANG L, BERMAN E: Familial occurrence of giant cell arteritis. J Rheumatol 1997; 24: 611-612 (Pubitemid 27153437)
61. GRANATO JE, ABBEN RP, WS MAY: Familial association of giant cell arteritis. A case report and brief review. Arch Intern Med 1981; 141: 115-117
62. NIELSEN JL: Polymyalgia rheumatica in a husband and wife. Scand J Rheumatol 1980; 9: 177-178
63. HICKSTEIN DD, GRAVELYN TR, WHARTON M: Giant cell arteritis and polymyalgia rheumatica in a conjugal pair. Arthritis Rheum 1981; 24: 1448-1450
64. KYLE MV, HAZLEMAN BL, KING RH: Polymyalgia rheumatica/giant cell arteritis in husband and wife. Clin Rheumatol 1984; 3: 395-396
65. GARFINKEL D, BOGRAD H, SALAMON F et al.: Polymyalgia rheumatica and temporal arteritis in a married couple. AM J Med Sci 1984; 287: 48-49 (Pubitemid 14088394)
66. BARRIER JH, BRISSEAU JM, LUCAS V, MAUGARD-LOUBOUTIN C, GROLEAU J, GROLLEAU JY: Giant cell arteritis in a conjugal pair. J Rheumatol 1988; 15: 383-384
67. GALETTA SL, RAPS EC, WULC AE et al.: Conjugal temporal arteritis. Neurology 1990; 40: 839-842
68. FAERK KK: Simultaneous occurrence of polymyalgia rheumatica in a married couple. J Intern Med 1992; 231: 621-622
69. LIOZON E, FAUCHAIS AL, LOUSTAUD V et al.: Concurrent temporal giant cell arteritis and malignancy: a study of 20 patients, with literature review. J Rheumatol 2006; 33: 1606-1614
70. REINHOLD-KELLER E, ZEIDLER A, GUTFLEISCH J, PETER HH, RASPE HH, GROSS WL: Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology 2000; 39: 1396-1402
71. SALVARANI C, GABRIEL SE, O'FALLON WM, HUNDER GG: Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991. Arthritis Rheum 1995; 38: 369-73.
72. MACHADO EB, GABRIEL SE, BEARD CM, MICHET CJ, O'FALLON WM, BALLARD DJ: A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? Int J Epidemiol 1989; 18: 836-841
73. DUHAUT P, PINEDE L, DEMOLOMBE-RAGUE S et al.: Giant cell arteritis and cardiovascular risk factors: a multicenter prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Arthritis Rheum 1998; 41: 1960-1965 (Pubitemid 28506685)